title: Similar efficacy of lopinavir/ritonavir-containing regimens among clades B and F HIV-1-Infected individuals in Brazil.
authors.forename: Ricardo Sobhie
authors.initials: RS
authors.lastname: Diaz
authors.forename: Lucy
authors.initials: L
authors.lastname: Vasconcelos
authors.forename: Ricardo L
authors.initials: RL
authors.lastname: Hayden
authors.forename: Simone
authors.initials: S
authors.lastname: Tenore
authors.forename: Gilberto
authors.initials: G
authors.lastname: Turcato
authors.forename: Ricardo
authors.initials: R
authors.lastname: Palácios
authors.forename: Maria C
authors.initials: MC
authors.lastname: Sucupira
mesh_terms: D001938:Brazil; D018791:CD4 Lymphocyte Count; D004338:Drug Combinations; D018432:Drug Resistance, Multiple / Q000235:genetics; D024882:Drug Resistance, Viral / Q000235:genetics; D005838:Genotype; D015658:HIV Infections / Q000097:blood / Q000188:drug therapy* / Q000821:virology; D017320:HIV Protease Inhibitors / Q000627:therapeutic use; D015497:HIV-1 / Q000187:drug effects* / Q000235:genetics; D006801:Humans; D061466:Lopinavir; D009154:Mutation; D011446:Prospective Studies; D011744:Pyrimidinones / Q000627:therapeutic use*; D012367:RNA, Viral / Q000097:blood / Q000235:genetics; D019438:Ritonavir / Q000627:therapeutic use*; D013995:Time; D013997:Time Factors; D016896:Treatment Outcome
chemical_list: D004338:Drug Combinations; D017320:HIV Protease Inhibitors; D011744:Pyrimidinones; D012367:RNA, Viral; D061466:Lopinavir; D019438:Ritonavir